Susanna High
Overview
Susanna High received an average of $2M in total compensation, including $390K in salary, at Dyne Therapeutics from 2020 to 2023.
Source: SEC filings on April 5, 2024, April 7, 2023, April 22, 2022, and April 14, 2021.
Related executives
We found five more executives who work or worked at Dyne Therapeutics.
News
Dyne Therapeutics CEO Josh Brumm's 2023 pay jumps 38% to $6M
April 5, 2024
Dyne Therapeutics CEO Joshua Brumm's 2022 pay rises 6% to $4.3M
April 7, 2023
Dyne Therapeutics CEO Joshua Brumm's 2021 pay falls 66% to $4.1M
April 22, 2022
Dyne Therapeutics CEO Joshua Brumm's 2020 pay jumps 981% to $12M
April 14, 2021